WO2008099198A3 - Osteogenic compounds - Google Patents

Osteogenic compounds Download PDF

Info

Publication number
WO2008099198A3
WO2008099198A3 PCT/GB2008/000544 GB2008000544W WO2008099198A3 WO 2008099198 A3 WO2008099198 A3 WO 2008099198A3 GB 2008000544 W GB2008000544 W GB 2008000544W WO 2008099198 A3 WO2008099198 A3 WO 2008099198A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
compounds
osteogenic compounds
osteogenic
piperidones
Prior art date
Application number
PCT/GB2008/000544
Other languages
French (fr)
Other versions
WO2008099198A2 (en
Inventor
Bikramjit Chopra
Grahame Mckenzie
Bryn Hardwick
Original Assignee
Inion Ltd
Bikramjit Chopra
Grahame Mckenzie
Bryn Hardwick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inion Ltd, Bikramjit Chopra, Grahame Mckenzie, Bryn Hardwick filed Critical Inion Ltd
Publication of WO2008099198A2 publication Critical patent/WO2008099198A2/en
Publication of WO2008099198A3 publication Critical patent/WO2008099198A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to certain 2- and 4-piperidones and their pharmaceutically acceptable salts and prodrugs, compositions comprising same and the use of these compounds and compositions as a medicament and in the manufacture of compositions for promoting bone regrowth and repair, and to methods of treating damaged or broken bones.
PCT/GB2008/000544 2007-02-16 2008-02-15 Osteogenic compounds WO2008099198A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0703061A GB2446652A (en) 2007-02-16 2007-02-16 Osteogenic compounds
GB0703061.2 2007-02-16

Publications (2)

Publication Number Publication Date
WO2008099198A2 WO2008099198A2 (en) 2008-08-21
WO2008099198A3 true WO2008099198A3 (en) 2009-01-15

Family

ID=37908776

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2008/000544 WO2008099198A2 (en) 2007-02-16 2008-02-15 Osteogenic compounds

Country Status (2)

Country Link
GB (1) GB2446652A (en)
WO (1) WO2008099198A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7947649B2 (en) 2008-04-14 2011-05-24 Advanced Technologies And Regenerative Medicine, Llc Liquid buffered GDF-5 formulations

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007234612B2 (en) 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
JP5323832B2 (en) 2007-08-07 2013-10-23 アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー Protein preparation containing GDF-5 in acidic aqueous solution

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355672B1 (en) * 1998-08-07 2002-03-12 Takeda Chemical Industries, Ltd. Benzothiepin derivatives, process for the preparation of the same and uses thereof
US6552054B1 (en) * 1999-09-01 2003-04-22 Takeda Chemical Industries, Ltd. Chromone derivatives, process for the preparation of the same and uses thereof
US20040142969A1 (en) * 2003-01-10 2004-07-22 Elworthy Todd Richard 2-Piperidone derivatives as prostaglandin agonists
US6926903B2 (en) * 2001-12-04 2005-08-09 Inion Ltd. Resorbable polymer composition, implant and method of making implant
US20050227969A1 (en) * 2002-12-04 2005-10-13 Xavier Billot EP4 receptor agonist, compositions and methods thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0208985A (en) * 2001-04-19 2004-03-09 Eisai Co Ltd 2-iminopyrrolidine derivatives
GB0220187D0 (en) * 2002-08-30 2002-10-09 Novartis Ag Organic compounds
WO2004064728A2 (en) * 2003-01-16 2004-08-05 Paratek Pharmaceuticals, Inc. Use of specific tetracycline compounds in therapy
GB0513702D0 (en) * 2005-07-04 2005-08-10 Sterix Ltd Compound

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355672B1 (en) * 1998-08-07 2002-03-12 Takeda Chemical Industries, Ltd. Benzothiepin derivatives, process for the preparation of the same and uses thereof
US6552054B1 (en) * 1999-09-01 2003-04-22 Takeda Chemical Industries, Ltd. Chromone derivatives, process for the preparation of the same and uses thereof
US6926903B2 (en) * 2001-12-04 2005-08-09 Inion Ltd. Resorbable polymer composition, implant and method of making implant
US20050227969A1 (en) * 2002-12-04 2005-10-13 Xavier Billot EP4 receptor agonist, compositions and methods thereof
US20040142969A1 (en) * 2003-01-10 2004-07-22 Elworthy Todd Richard 2-Piperidone derivatives as prostaglandin agonists

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DEPRAETERE S ET AL: "Polar agents with differentiation inducing capacity potentiate tumor necrosis factor-mediated cytotoxicity in human myeloid cell lines", JOURNAL OF LEUKOCYTE BIOLOGY 1995 US, vol. 57, no. 1, 1995, pages 141 - 151, XP002500355, ISSN: 0741-5400 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7947649B2 (en) 2008-04-14 2011-05-24 Advanced Technologies And Regenerative Medicine, Llc Liquid buffered GDF-5 formulations

Also Published As

Publication number Publication date
GB0703061D0 (en) 2007-03-28
WO2008099198A2 (en) 2008-08-21
GB2446652A (en) 2008-08-20

Similar Documents

Publication Publication Date Title
PT2383271E (en) Aminoquinolones as gsk-3 inhibitors
WO2006089023A3 (en) Pharmaceutical compositions for treating or preventing bone conditions
HK1137366A1 (en) Pharmaceutical compositions comprising activin-actriia antagonists and use thereof in preventing or treating multiple myeloma
WO2009118662A3 (en) Methods and compositions for treating bone loss
WO2007027527A3 (en) Isoindole-imide compounds and compositions comprising and methods of using the same
WO2011005493A3 (en) Methods and materials for tissue repair
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
WO2007092622A3 (en) Compositions and methods for treating bone
WO2008148873A3 (en) Hydroxyproline compositions and uses thereof
BRPI0913293A2 (en) method for inhibiting biofilm formation, topical pharmaceutical composition, surgical rinsing, bandage, cleaning composition, and dental rinsing.
EP2175800A4 (en) Composite implant for surgical repair
WO2009035634A3 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors
WO2009009620A3 (en) Acellular tissue matrix compositions for tissue repair
ZA201000279B (en) Tissue fragment composition for the treatment of incontinence
IL187522A0 (en) Lkktet and/or lkktnt compositions and methods for treating or preventing tissue deterioration, injury or damage
EP1962867A4 (en) Biocompatible surgical compositions
WO2009040420A3 (en) Use of a monoterpene to increase tissue repair
WO2007054939A3 (en) Method for non-autologous cartilage regeneration
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders
WO2009022133A3 (en) Scaffolds
WO2009114535A3 (en) Bone paste composition
WO2008052139A3 (en) Ultra low dose doxepin and methods of using the same to treat sleep disorders
WO2007136741A3 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
EP2114457A4 (en) Composition for promoting bone regeneration and restoration
EP1960446A4 (en) Biocompatible surgical compositions

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08709432

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08709432

Country of ref document: EP

Kind code of ref document: A2